James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,484
Out of 5,106 analysts
8
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $24.13 | +16.04% | 3 | Aug 5, 2025 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.34 | +1,364.56% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $84.00 | -59.52% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $9.56 | +538.08% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $24.13
Upside: +16.04%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.34
Upside: +1,364.56%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $84.00
Upside: -59.52%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $9.56
Upside: +538.08%